Tellgen Corporation (300642.SZ): Subsidiary's application for medical device registration has been accepted.

Tellgen Corporation (300642.SZ) announced that its wholly-owned subsidiary, Jiangxi Tellgen Corporation Technology Co., Ltd. ("Jiangxi Tellgen"), has recently received acceptance from the Jiangxi Provincial Drug Administration for its medical device registration application. The product names are as follows: Thrombin-Antithrombin III Complex Determination Reagent Kit (Chemiluminescent Immunoassay), Thrombin Regulating Protein Determination Reagent kit (Chemiluminescent Immunoassay), Plasmin-2 Plasmin Inhibitor Complex Determination Reagent Kit (Chemiluminescent Immunoassay), Fibrin(ogen) Degradation Product Determination Reagent Kit (Chemiluminescent Immunoassay), Tissue Plasminogen Activator-Plasminogen Activator Inhibitor-1 Complex Determination Reagent Kit (Chemiluminescent Immunoassay), and Thrombus Multi-Item Quality Control Kit.